ArticleTurkish journal of medical sciences2026
Association of occupational lead exposure with erythrocytic parameters and nitric oxide-related metabolites: a case-control study.
Article in Turkish journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/aim: Occupational lead (Pb) exposure remains a significant public health concern due to its persistent presence in industrial environments and its cumulative toxic effects. Although the hematological and neurological consequences of Pb exposure are well documented, early vascular effects and the mechanisms associated with potential endothelial impairment remain unclear. This study aimed to investigate the associations between Pb exposure, erythrocytic parameters, and nitric oxide (NO)-related metabolites (asymmetric dimethylarginine [ADMA], symmetric dimethylarginine [SDMA], arginine, homoarginine, and citrulline) to identify early biomarkers that may suggest impairment in NO-related pathways. Materials and methods: This case-control study included a strictly selected cohort of 125 occupationally Pb-exposed workers and 125 healthy controls without known occupational exposure. To minimize confounding, all participants were strict nonsmokers and nondrinkers with no history of chronic disease. Blood Pb levels, hematological parameters, and metabolic biomarkers, including arginine, ADMA, SDMA, homoarginine, and citrulline, were analyzed using standardized laboratory methods. Associations between Pb levels, erythrocyte indices, and amino acid-related metabolites were evaluated using correlation analysis. Results: Blood Pb concentrations were significantly higher in the Pb-exposed group. Pb-exposed individuals had significantly lower hemoglobin (Hb) levels. While ADMA levels did not differ significantly between groups, SDMA levels were higher and citrulline levels were lower in the exposed workers. Ferritin levels were lower, whereas transferrin and total iron-binding capacity levels were higher in the exposed group. In multivariable analyses adjusted for age and body mass index, blood Pb levels were associated with higher SDMA levels and lower Hb, citrulline, and ferritin levels. Conclusion: Occupational Pb exposure was associated with alterations in erythrocytic indices and NO-related metabolic markers, which may be consistent with impairment in NO-related pathways. However, because of the case-control design and the absence of direct endothelial function measurements, these findings should be interpreted as associative rather than causal.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.